OLD National Bancorp IN Has $559,000 Stake in Chimera Investment Corporation (CIM)

OLD National Bancorp IN held its position in Chimera Investment Corporation (NYSE:CIM) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 30,000 shares of the real estate investment trust’s stock at the end of the second quarter. OLD National Bancorp IN’s holdings in Chimera Investment Corporation were worth $559,000 at the end of the most recent reporting period.

Other institutional investors have also recently bought and sold shares of the company. Credit Agricole S A purchased a new position in Chimera Investment Corporation during the fourth quarter worth $110,000. Zurcher Kantonalbank Zurich Cantonalbank boosted its position in Chimera Investment Corporation by 80.9% in the first quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 7,869 shares of the real estate investment trust’s stock worth $159,000 after buying an additional 3,519 shares during the last quarter. Sit Investment Associates Inc. boosted its position in Chimera Investment Corporation by 143.6% in the first quarter. Sit Investment Associates Inc. now owns 9,500 shares of the real estate investment trust’s stock worth $192,000 after buying an additional 5,600 shares during the last quarter. Snow Capital Management LP purchased a new position in Chimera Investment Corporation during the first quarter worth $201,000. Finally, National Asset Management Inc. purchased a new position in Chimera Investment Corporation during the first quarter worth $217,000. 55.66% of the stock is owned by institutional investors.

Chimera Investment Corporation (NYSE CIM) opened at 18.65 on Monday. Chimera Investment Corporation has a 12 month low of $14.70 and a 12 month high of $20.90. The company has a market cap of $3.50 billion, a PE ratio of 5.62 and a beta of 0.93. The stock’s 50 day moving average is $18.75 and its 200 day moving average is $18.76.

Chimera Investment Corporation (NYSE:CIM) last issued its earnings results on Monday, May 1st. The real estate investment trust reported $0.51 earnings per share for the quarter, missing the consensus estimate of $0.58 by $0.07. Chimera Investment Corporation had a net margin of 64.18% and a return on equity of 14.14%. The business had revenue of $141.11 million for the quarter, compared to analyst estimates of $140.90 million. During the same quarter last year, the firm posted $0.58 earnings per share. Chimera Investment Corporation’s revenue was up 2.1% on a year-over-year basis. Equities analysts predict that Chimera Investment Corporation will post $2.37 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 28th. Stockholders of record on Friday, June 30th will be given a dividend of $0.50 per share. The ex-dividend date is Wednesday, June 28th. This represents a $2.00 annualized dividend and a dividend yield of 10.72%. Chimera Investment Corporation’s dividend payout ratio (DPR) is currently 60.24%.

COPYRIGHT VIOLATION NOTICE: “OLD National Bancorp IN Has $559,000 Stake in Chimera Investment Corporation (CIM)” was originally reported by Ticker Report and is owned by of Ticker Report. If you are accessing this report on another website, it was copied illegally and reposted in violation of U.S. and international copyright & trademark legislation. The legal version of this report can be accessed at https://www.tickerreport.com/banking-finance/2722344/old-national-bancorp-in-has-559000-stake-in-chimera-investment-corporation-cim.html.

Several equities analysts have recently commented on the stock. Zacks Investment Research raised shares of Chimera Investment Corporation from a “strong sell” rating to a “hold” rating in a research report on Tuesday, July 4th. BidaskClub raised shares of Chimera Investment Corporation from a “hold” rating to a “buy” rating in a research report on Thursday, June 15th. Barclays PLC set a $17.00 price target on shares of Chimera Investment Corporation and gave the stock a “hold” rating in a research report on Monday, May 8th. Finally, ValuEngine raised shares of Chimera Investment Corporation from a “buy” rating to a “strong-buy” rating in a research report on Saturday, June 3rd. Seven investment analysts have rated the stock with a hold rating, one has issued a buy rating and one has assigned a strong buy rating to the stock. Chimera Investment Corporation presently has an average rating of “Hold” and a consensus target price of $17.75.

About Chimera Investment Corporation

Chimera Investment Corporation is a real estate investment trust (REIT). The company is engaged in the business of investing in a portfolio of mortgage assets, including agency residential mortgage-backed security (RMBS), non-agency RMBS, agency commercial mortgage-backed securities (CMBS), residential mortgage loans and real estate related securities.

Want to see what other hedge funds are holding CIM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chimera Investment Corporation (NYSE:CIM).

Institutional Ownership by Quarter for Chimera Investment Corporation (NYSE:CIM)

Receive News & Ratings for Chimera Investment Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chimera Investment Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
Shares at Radius Jump as Bone Drug of Amgen Has Setback
Shares at Radius Jump as Bone Drug of Amgen Has Setback


Leave a Reply

© 2006-2017 Ticker Report. Google+.